These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12812042)

  • 1. [Reactions of derivatives of beta-lactam antibiotics with non-antibacterial biological activity].
    Gunda T
    Acta Pharm Hung; 2002; 72(4):223-30. PubMed ID: 12812042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
    Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA
    Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
    Buynak JD
    Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
    J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors.
    Coleman K
    Curr Opin Microbiol; 2011 Oct; 14(5):550-5. PubMed ID: 21840248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic properties of beta-lactamase inhibitors.
    de la Pena A; Derendorf H
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):63-75. PubMed ID: 10082170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial agents: patent highlights January 2005 to June 2005.
    Phillips OA
    Curr Opin Investig Drugs; 2005 Aug; 6(8):768-80. PubMed ID: 16121683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indicator method of determining the beta-lactamase-inhibiting activity of various compounds].
    Ivanitskaia LP; Nikishina VG
    Antibiotiki; 1981 Apr; 26(4):259-64. PubMed ID: 6972191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams.
    Ekström B
    Scand J Infect Dis Suppl; 1984; 42():38-49. PubMed ID: 6335599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of beta-lactamases on the development of novel antimicrobial agents.
    Bush K
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1284-90. PubMed ID: 12498001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallo-beta-lactamase inhibitors: promise for the future?
    Toney JH; Moloughney JG
    Curr Opin Investig Drugs; 2004 Aug; 5(8):823-6. PubMed ID: 15600238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assays for beta-lactamase activity and inhibition.
    Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI
    Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Kumagai T; Petersen PJ; Weiss WJ; Lenoy E; Yang Y; Shlaes DM; Ryan JL; Mansour TS
    Bioorg Med Chem; 2004 Nov; 12(22):5807-17. PubMed ID: 15498657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of a novel fluorescent biosensor for beta-lactam antibiotics from a class A beta-lactamase.
    Chan PH; Liu HB; Chen YW; Chan KC; Tsang CW; Leung YC; Wong KY
    J Am Chem Soc; 2004 Apr; 126(13):4074-5. PubMed ID: 15053574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics.
    Badarau A; Llinás A; Laws AP; Damblon C; Page MI
    Biochemistry; 2005 Jun; 44(24):8578-89. PubMed ID: 15952764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [beta-Lactamase inhibition as 1 of the ways of overcoming resistance to beta-lactam antibiotics].
    Prokopenko VM; Tereshin IM
    Antibiotiki; 1979 Nov; 24(11):867-73. PubMed ID: 389155
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in the chemistry of beta-lactam compounds as selected active-site serine beta-lactamase inhibitors.
    Mascaretti OA; Danelon GO; Laborde M; Mata EG; Setti EL
    Curr Pharm Des; 1999 Nov; 5(11):939-53. PubMed ID: 10539998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.